The results of hip and knee replacement surgery are generally regarded as positive for patients. Nonetheless, they are both major operations and have recognised complications. We present a review of relevant claims made to the National Health Service Litigation Authority. Between 1995 and 2010 there were 1001 claims to a value of £41.5 million following hip replacement surgery and 523 claims to a value of £21 million for knee replacement. The most common complaint after hip surgery was related to residual neurological deficit, whereas after knee replacement it was related to infection. Vascular complications resulted in the highest costs per case in each group.
Introduction
The National Health Service Litigation Authority (NHSLA) was created in 1995 to indemnify National Health Service Trusts in England. Initially it was only responsible for larger claims, but since 2002 has kept data on all claims made against the NHS. Up to March 2010 the NHSLA has handled more than 57 000 claims for negligence of all types, of which more than 22 400 were related to surgery (excluding obstetrics and gynaecology), at a total cost of £1.82 billion.[ [1, 2] ] In the year 2010/2011 it made payments of more than £729 million for clinical negligence.[ [3] ] The NHSLA estimates that its potential liabilities for all clinical negligence are in the region of £16.6 billion. [[3] ] This aim of this study was to review claims made through the NHSLA relating to hip and knee replacement surgery, to explore the reasons for litigation and to explore trends over time.
Hip and knee replacement surgery produce some of the highest health gains, both in terms of improvement in quality of life and in cost-effectiveness.[ [4] [5] [6] ] Both are major procedures, however, and are associated with well-recognised morbidity and, rarely, mortality.[ [7, 8] When total claims for negligence are considered year on year, based on the year of incident as opposed to the year in which the claim was made, the number of claims recorded by the NHSLA has remained relatively stable. Between 1995 and 2006 the mean number of claims per year was 5701 (5190 to 6282), although owing to the varying time interval between incident and claim it cannot be determined with any certainty how this trend has evolved in recent years.[ [1] ] There is, however, a general perception that litigation for alleged medical negligence is increasing. [[11] ] This perception has led to concern that surgeons are practising defensively at the expense of best practice.[ [11] [12] [13] 
Materials and Methods
In 2011, a freedom of information request was made to the NHSLA asking for data about all claims involving orthopaedics and trauma, to include year of incident, the year the claim was made, the nature of the claim and, where applicable, the costs incurred (defence costs, claimant costs and damages paid). Data were provided by NHSLA from the period 1995/96 to 2009/10. These data were then filtered to include only those cases involving hip and knee replacement. Definitions such as 'hip operation' or 'knee operation' were considered ambiguous and therefore excluded from this analysis. The details of each claim were then categorised and are summarised in Tables I and II.   Table I Owing to the nature of the descriptions attached to a given claim, no distinction was made between the various types of hip and knee replacements. As a claim for negligence may arise from cumulative dissatisfaction, many claims attribute more than one cause for complaint, meaning that there are more 'causes' discussed than individual claims.
Consequently, an individual claim may appear more than once in the data as each cause is included separately. Where either 'no costs' or only 'defence costs' were incurred, this was taken to mean that the case was successfully defended (provided the case was closed).
Where either claimant's costs or damages were paid, this was interpreted as the NHS having lost the case. The data were then sorted to compare, for each cause of claim, the total number of claims closed and the total number of these claims that were paid out. 
Results
Over the study period a total of 22 500 claims were made to the NHSLA relating to surgery (excluding obstetrics and gynaecology), with costs > £1.8 billion. Of these, 8950 (40%) involved orthopaedics at a cost of £402 million (22%).
Of the orthopaedic claims, 1527 (17%) were related to hip or knee replacement surgery. The value of these claims to date exceeds £62 million, or 15.5% of the total awards made in relation to orthopaedic surgery. Of the claims, 224 (14.6%) remain 'open'
or unsettled at the time of writing (136 hips and 88 knees).
Hip replacement surgery accounted for 1001 of the claims, at a current cost of over £41.5 million. This corresponds to 11% of orthopaedic claims and 10% of the overall cost.
After knee replacement surgery 523 claims had been made, at a cost of £21 million, which represented 6% of all orthopaedic claims and 5% of the total cost.
Causes of claims data
A summary of claims relating to hip replacement surgery is detailed in Table III . A total of 413 of 1001 claims were paid out. The mean total cost of contested cases that were subsequently lost and where damages were paid was £98 000. *refers to % of total claims that incurred claimant's cost and/or damages † includes all costs, defence, claimants and damages ‡ mean cost of contested claims subsequently lost
The highest single cost, at > £1.05 million, arose from a case of vascular injury in which the involvement of the vascular surgeons was delayed, resulting in compartment syndrome. Although cited as a cause in only 13 (1.1%) of claims, vascular injury resulted in the highest mean pay-outs. A further four of the 13 claims resulted in compensation > £100 000, one of which was > £1 million. These four claims addressed major vessel injury, compartment syndrome, amputation and one death.
Other causes of litigation that resulted in compensation above the mean of £98 000
were infection, neurological deficit, technical error, pain and dislocation. A 'miscellaneous' group included 13 paid claims which cost more than £100 000, 12 of which were nonspecified 'dissatisfaction' with outcome.
Comparable data on claims for knee replacement surgery are summarised in Table IV. A total of 218 of 523 claims were paid out, with a mean cost for cases contested and loss of £93 000. The highest single cost was for a vascular injury that resulted in compartment syndrome and subsequent amputation. Vascular injuries accounted for 4.2% of claims but generated the highest mean cost (£232 900). There were ten further claims that resulted in payments of more than the mean figure for knee replacements (£93 000). Seven of these involved compartment syndrome, amputation or both, and the remaining three cases were for vascular injury or ischaemia. * refers to % of total claims that incurred claimant's cost and/or damages † includes all costs, defence, claimants and damages ‡ mean cost of contested claims subsequently lost
Other causes that resulted in mean costs greater than average were prosthesis failure, infection, neurological deficit, dislocation, and DVT/PE. (Table V) . Although the absolute number of claims after hip replacement was relatively stable, there was an increase over the two time periods in the proportion of claims for injury resulting in neurological deficit, which is now the commonest cause of litigation for hip replacement surgery. The time trend data for knee replacement show a 46% increase in the total number of claims, from 232 to the end of 2002/03 to 337 in 2009/10 (Table VI) . Within the individual categories there is evidence of considerable change in the cited reason for bringing a case. 'Alleged negligence' increased from 5% to 16%, 'technical error -component' and 'technical error -other' increased by 5% and 4%, respectively.
Trends
Conversely, the proportion of claims associated with infection dropped from 20% to 14%, 'miscellaneous' fell from 13% to 8%, 'post-operative care' from11% to 8%, neurological deficit from 9% to 5%, and vascular causes from 6% to 3%.
Discussion
Despite an increase in the number of hip replacements being carried out during the study The NHSLA information is intended primarily for claims management. The data are not structured for clinical purposes, and the clinical detail within the claim is limited to the major points of the claim. Furthermore, before April 2002 the NHSLA did not specifically collect data on cases below a certain level (varying between £10 000 and £50 000), so it is not possible to draw specific conclusions about trends before this date.
One assumption we were required to make in this analysis was the absence of coliability. It is possible that there were other unknown and confounding factors whereby a patient had a reasonable claim for an NHS operation but the NHSLA was not found to be
liable. An example of this would be the claims associated with the 3M hip, in which the liability for costs was passed to the third party.
The current analysis also only addresses legal challenges that followed alleged negligence, and there are likely to be occasions where clinical negligence has occurred but litigation has not been pursued, and conversely, cases where clinical negligence has not been proven or admitted but a settlement has been agreed.
Although the current data provide an overview of the causes of litigation, it has not been possible to distinguish between the different types of joint replacement operation performed, such as hip resurfacing, unicondylar knee replacement, patellofemoral joint and more established total replacements. Further work on the patterns of poor outcome and legal intervention associated with specific techniques would be instructive.
This study shows that over the last decade or so the absolute number of claims made against the NHSLA for hip replacement surgery has remained fairly stable, but has decreased as a proportion of the total procedures performed. Furthermore, the reasons for the claims are consistent and generally well recognised by surgeons.
There have, however, been changes in the pattern of litigation for knee replacement surgery, and although cases of infection have reduced in number, a previously small and non-specific category where there is simply 'alleged negligence' has notably increased. This is of concern for surgeons, as it is difficult to plan against such a non-specific allegation and it does not help refine techniques or improve outcomes.
Of equal concern is that there are three categories ('technical error -component', 'technical error -other' and 'post-operative care'), which appear on nearly a third of the claims but are not specifically discussed on the BOA consent form. We suggest that the pre-operative consenting process might be refined to draw explicit links between nonspecific features such as pain and the possibility of technical shortcomings in the procedure.
It is encouraging that litigation for infection has diminished after both THR and TKR:
this may reflect improvement in practice. There remains a large group of patients who sue the NHS for poorly specified reasons, but the NHSLA data provide no evidence to suggest that orthopaedic surgeons are, within the bounds of the NHS, subject to a more litigious culture.
